DUBLIN, February 5, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/r5d88l/molecular) has announced the addition of the "Concise Analysis of International Molecular Diagnostics in Genetic Testing" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


Molecular diagnostics in genetic testing brings advanced analytical techniques to the diagnosis and treatment of genetic disorders. The confluence of breakthroughs in genomics and proteomics and the development of microarray devices to measure analytes in the blood and various body tissues are driving significant growth in the segment. 

Major developments include the integration of specialty labs and gene expression profiling into clinical practice, the introduction and rapid growth of cell-free fetal DNA prenatal testing, the advancement of companion diagnostics for drug development, the widespread installed base of automated instruments for molecular testing and the development of personalized medicine. The genetic testing space is one of the most profitable sectors of molecular diagnostics and is expected to be an area of high growth and corporate change throughout the forecast period. 

This report describes the emerging field of molecular diagnostics in genetic testing. This review analyzes the size and growth of the molecular diagnostics in genetic testing market, including the factors that influence the various market segments within it and the dollar volume of sales, both in the United States and worldwide. Moreover, this analysis profiles the leading companies focused on the molecular diagnostics for genetic testing sector. 

Key Topics Covered: 

1. Overview 

2. Role of Molecular Diagnostics and Opportunities in the Genetic Testing Sector 

3. Introduction to Molecular Diagnostics Technology for Genetic Testing 

4. Business Landscape for Molecular Diagnostics in Genetic Testing 

5. Molecular Diagnostic Assays and Select Laboratories for Genetic Testing on the Market 

6. Reimbursement and Billing Landscape for Molecular Diagnostic Genetic Testing 

7. Regulatory Issues for Genetic Testing

8. Business Decisions, Strategic Outlook and Recommendations Using Molecular Diagnostic Tests in Genetic Testing 

9. Company Profiles 


Companies Mentioned:

• Abbott Laboratories
• Beckman Coulter
• CombiMatrix
• EntroGen, Inc
• Genmark Diagnostics, Inc
• Genomic Health
• Hologic, Inc
• Illumina, Inc
• IntegenX
• Laboratory Corporation of America Holdings
• Life Technologies Corporation
• Luminex Corporation
• Myriad Genetics, Inc
• Natera
• NetBio
• PerkinElmer Genetics
• Progenika, Inc
• Roche Diagnostics
• Sequenom, Inc
• Signature Genomics
• Spartan Bioscience, Inc
• Transgenomic, Inc

For more information visit http://www.researchandmarkets.com/research/r5d88l/molecular

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets